The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
IMJUDO tremelimumab 300 mg/ 15 mL concentrated injection vial (2023-24)
Product name
IMJUDO tremelimumab 300 mg/ 15 mL concentrated injection vial
Sponsor name
AstraZeneca Pty Ltd
Year Range
2023-24